340B Fight: Lilly ‘Disagrees’ With HHS Advisory Stating Discounts To Contract Pharmacies Are Required

 
• By Cathy Kelly

Lilly will not change its 340B discount restrictions in light of the advisory, which was released after HHS was sued by hospitals and other groups seeking a regulatory response against pharma actions.

Claims That Contract Pharmacies Aren't Passing Along Discounts To Patients

More from Pricing Debate

More from Market Access